Alembic Pharmaceuticals reports 2- fold jump in Q1 consolidated net profit

23 Jul 2020 Evaluate

Alembic Pharmaceuticals has reported results for first quarter ended June 30, 2020.

The company has reported 2- fold jumps in its net profit of Rs 318.64 crore for the quarter under review as against Rs 155.22 crore for the same quarter in the previous year. Total income of the company increased 39.86% at Rs 1258.59 crore for Q1FY21 as compared Rs 899.92 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported over 2- fold jumps in its net profit after taxes, non-controlling interests and share of profit of Associates and Joint Ventures at Rs 301.46 crore for the quarter under review as against Rs 123.72 crore for the same quarter in the previous year. Total income of the company increased by 40.90% at Rs 1341.64 crore for Q1FY21 as compared Rs 952.20 crore for the corresponding quarter previous year.

Alembic Pharma Share Price

877.15 -7.95 (-0.90%)
12-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1794.30
Dr. Reddys Lab 1279.65
Cipla 1517.20
Zydus Lifesciences 929.05
Lupin 2114.10
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×